Bath & Body Works, Inc. $BBWI Shares Purchased by First Trust Advisors LP

First Trust Advisors LP increased its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 19.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 596,754 shares of the company’s stock after buying an additional 98,296 shares during the quarter. First Trust Advisors LP’s holdings in Bath & Body Works were worth $11,141,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in the business. AQR Capital Management LLC grew its holdings in Bath & Body Works by 132.5% in the 4th quarter. AQR Capital Management LLC now owns 11,445,928 shares of the company’s stock valued at $229,834,000 after buying an additional 6,523,960 shares during the period. Alliancebernstein L.P. increased its stake in shares of Bath & Body Works by 5.8% during the 2nd quarter. Alliancebernstein L.P. now owns 5,737,796 shares of the company’s stock valued at $171,904,000 after acquiring an additional 315,738 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Bath & Body Works by 2.9% in the fourth quarter. Geode Capital Management LLC now owns 3,960,475 shares of the company’s stock worth $79,542,000 after acquiring an additional 110,602 shares during the last quarter. Bank of America Corp DE grew its holdings in Bath & Body Works by 86.9% in the third quarter. Bank of America Corp DE now owns 3,399,390 shares of the company’s stock valued at $87,568,000 after purchasing an additional 1,580,176 shares during the period. Finally, Vaughan Nelson Investment Management L.P. grew its holdings in Bath & Body Works by 33.8% in the first quarter. Vaughan Nelson Investment Management L.P. now owns 2,852,040 shares of the company’s stock valued at $53,248,000 after purchasing an additional 719,795 shares during the period. 95.14% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have weighed in on BBWI shares. Telsey Advisory Group decreased their price target on shares of Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating on the stock in a report on Thursday, May 28th. Barclays dropped their price objective on Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a report on Thursday, May 28th. TD Cowen increased their target price on Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Piper Sandler began coverage on Bath & Body Works in a report on Friday, May 15th. They issued a “neutral” rating and a $20.00 target price on the stock. Finally, UBS Group lowered their price target on Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, May 20th. Three research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $21.93.

Bath & Body Works Stock Up 0.9%

Shares of BBWI stock opened at $20.13 on Friday. Bath & Body Works, Inc. has a fifty-two week low of $14.27 and a fifty-two week high of $32.32. The firm’s 50 day moving average price is $20.15 and its two-hundred day moving average price is $20.37. The stock has a market cap of $4.06 billion, a price-to-earnings ratio of 5.66, a price-to-earnings-growth ratio of 1.97 and a beta of 1.38.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.03. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The company had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.36 billion. During the same quarter in the prior year, the business earned $0.49 earnings per share. The business’s quarterly revenue was down 3.2% compared to the same quarter last year. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, equities analysts forecast that Bath & Body Works, Inc. will post 2.63 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 19th. Shareholders of record on Friday, June 5th were paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.0%. The ex-dividend date was Friday, June 5th. Bath & Body Works’s payout ratio is currently 22.47%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.